Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...

A meta-analysis shows varying effectiveness of treatments in restoring smell in patients with chronic rhinosinusitis with ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...

Tezspire is the first biologic approved for CRSwNP targeting TSLP, expanding its respiratory indications. The drug acts on airway epithelium, inhibiting TSLP, an early-stage inflammatory cytokine. The ...

Approval broadens indication for TEZSPIRE to a second disease characterized by epithelial-driven inflammation AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the ...

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE ® (tezepelumab-ekko) for the ...

Jason Aldean says he hasn’t been able to smell well for at least a decade. The country music superstar, 48, recently appeared on Armchair Expert With Dax Shepard, where he discussed various topics, ...

Please provide your email address to receive an email when new articles are posted on . Nasal polyp and congestion scores dropped more with stapokibart vs. placebo. Overall nasal symptoms, sense of ...

You may develop nasal polyps when your nasal passages or sinuses are constantly irritated and swollen. These soft, noncancerous growths can be found in nasal passages and sinuses and form from the ...